Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles

por Venkatakrishnan, K, Burgess, C, Gupta, N, Suri, A, Takubo, T, Zhou, X, DeMuria, D, Lehnert, M, Takeyama, K, Singhvi, S, Milton, A
Publicado 2016